BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/6/2026 6:30:39 AM | Browse: 55 | Download: 141
 |
Received |
|
2025-11-11 11:52 |
|
Peer-Review Started |
|
2025-11-12 00:23 |
|
First Decision by Editorial Office Director |
|
2025-11-24 12:38 |
|
Return for Revision |
|
2025-11-24 12:38 |
|
Revised |
|
2025-12-01 16:59 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-24 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-24 10:44 |
|
Articles in Press |
|
2025-12-24 10:44 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-29 10:16 |
|
Publish the Manuscript Online |
|
2026-02-06 06:30 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Role of claudin-6 in high-grade endometrial carcinoma: Implications for risk stratification and personalized treatment strategies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chuang Cai, Jin-Man Chen, Zu-Xun Qiu and Shu-Qi Ren |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Zhongshan Science and Technology Bureau |
2023B1033 |
|
| Corresponding Author |
Shu-Qi Ren, Associate Research Scientist, Department of Laboratory Medicine, Zhongshan Integrated Traditional Chinese and Western Medicine Hospital, No. 10 Dexiu Road, Zhongshan 528467, Guangdong Province, China. shuchijen@163.com |
| Key Words |
Claudin-6; High-grade endometrial carcinoma; Risk stratification; Therapeutic target; Prognosis |
| Core Tip |
This editorial focuses on the expression and clinical importance of the tight junction protein claudin-6 (CLDN6) in high-grade endometrial carcinoma. It demonstrates that CLDN6 overexpression independently correlates with aggressive pathological characteristics and poor patient outcomes. These findings underscore CLDN6’s value as a prognostic biomarker and highlight its potential as a therapeutic target, opening new possibilities for improved risk stratification and personalized treatment strategies in high-grade endometrial carcinoma. |
| Publish Date |
2026-02-06 06:30 |
| Citation |
Cai C, Chen JM, Qiu ZX, Ren SQ. Role of claudin-6 in high-grade endometrial carcinoma: Implications for risk stratification and personalized treatment strategies. World J Clin Oncol 2026; 17(2): 116390 |
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i2/116390.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v17.i2.116390 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
